HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer.

AuthorsKai-Lung Chen, Chia-Chi Lin, Yung-Tsu Cho, Che-Wen Yang, Yi-Shuan Sheen, Hsiao-En Tsai, Chia-Yu Chu
JournalJAMA dermatology (JAMA Dermatol) Vol. 152 Issue 3 Pg. 340-2 (Mar 2016) ISSN: 2168-6084 [Electronic] United States
PMID26649681 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Quinazolines
  • Afatinib
  • Erlotinib Hydrochloride
  • Gefitinib
Topics
  • Acneiform Eruptions (chemically induced, epidemiology)
  • Afatinib
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Cohort Studies
  • Compassionate Use Trials
  • Cross-Sectional Studies
  • Drug Eruptions (diagnosis, etiology)
  • Erlotinib Hydrochloride (adverse effects, therapeutic use)
  • Gefitinib
  • Humans
  • Ichthyosis (chemically induced, epidemiology)
  • Lung Neoplasms (drug therapy)
  • Paronychia (chemically induced, epidemiology)
  • Pruritus (chemically induced, epidemiology)
  • Quinazolines (adverse effects, therapeutic use)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: